Home > Insider Trading > Filing (0001209191-17-059504)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624658	Allena Pharmaceuticals Inc.	ALNA	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1456654	Fhm Vi, L.l.c.	C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456655	Fhm Vi, L.p.	C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456656	Frazier Healthcare Vi, L.p.	C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-06	2,830,373	$0.00	2,830,373	No	4	C	Indirect	By Frazier Healthcare VI, L.P.
Common Stock	Acquisiton	2017-11-06	500,000	$14.00	3,330,373	No	4	P	Indirect	By Frazier Healthcare VI, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Frazier Healthcare VI, L.P.
No	4	P	Indirect	By Frazier Healthcare VI, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-11-06	6,122,448	$0.00	1,466,805	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-11-06	4,629,630	$0.00	1,109,159	$0.00
Common Stock	Series C Preferred Stock	Disposition	2017-11-06	1,061,904	$0.00	254,409	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Series A Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
The Series B Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
The Series C Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
The securities are held by Frazier Healthcare VI, L.P. ("Frazier VI"). FHM VI, L.P. ("FHM LP") is the general partner of Frazier VI and FHM VI, L.L.C. ("FHM LLC") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein.
Not applicable.